Iodopol, 37-7400 MBq, hard capsules

Specyfikacja
Okres ważności: 

21 days from the manufacturing date

Warunki przechowywania: 

 

Store below 25°C.

 

Store in the original package to avoid radiation exposure from the product.

 

Storage of radiopharmaceuticals should be in accordance with national regulations on radioactive materials.

 

Postać farmaceutyczna: 

 

Hard capsule.

 

Medium orange hard gelatin capsule, approximately 18 mm long, containing white powder.

 

Skład jakościowy i ilościowy substancji czynnych: 

 

One capsule contains sodium iodide (131I) 37 - 7400 MBq at time of calibration.

 

Wykaz substancji pomocniczych: 

 

Capsule contents:

 

Sodium carbonate

 

Sodium hydrogen carbonate

 

Sodium hydroxide

 

Disodium phosphate dihydrate

 

Sodium thiosulfate

 

 

 

Gelatin capsule shell composition:

 

Quinoline yellow (E 104)

 

Erythrosine (E 127)

 

Titanium dioxide (E 171)

Gelatin

Rodzaj i zawartość opakowania: 

 

The polypropylene vial placed in a shielding lead container, closed with a lead stopper which contains polypropylene insert with iodine absorber. The package contains a single capsule. Each package is accompanied by a separate polypropylene applicator for capsule administration.

Wskazania do stosowania: 

 

Radioiodide thyroid therapy is indicated in adults and children for:

 

- hyperthyroidism: treatment of Graves’ disease, toxic multinodular goitre or autonomous nodules. 

 

- treatment of large euthyroid (nontoxic) goitre.

 

- treatment of papillary and follicular thyroid carcinoma, including metastatic disease. 

 

Sodium Iodide (131I) therapy is often combined with surgical intervention and with antithyroid medicinal products.

 

Załączniki: 
Pliki




	
	
  

Nasza siedziba

Produkty

Certyfikaty